LITTLE KNOWN FACTS ABOUT (+)-JQ-1 MECHANISM OF ACTION.

Semaglutide, a glucagon like peptide-one (GLP-one) receptor agonist, is out there as monotherapy in both of those subcutaneous along with oral dosage form (very first authorised oral GLP-one receptor agonist). It's been accepted like a second line remedy option for much better glycaemic Manage in sort two diabetes and currently underneath scrutiny